How I do it: > 8 Carmustine wafer implantation during supra-marginal resection of a glioblastoma, IDH-wildtype.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 40971079.
- Also identified by DOI 10.1007/s00701-025-06675-5 and PMC identifier 12449338.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The maximal safe resection of glioblastoma, IDH-wildtype often creates a large resection cavity that can accommodate more than eight Carmustine implants. We detail the implantation technique of 13 Carmustine wafers within the surgical bed after a right hippocampal formation-sparing anterior temporal lobectomy allowing for the supra-marginal resection of a glioblastoma IDH-wildtype in an adult patient. Carmustine wafer implantation is a safe and efficient technique following surgical resection of a glioblastoma, IDH-wildtype. Sequential technical steps are required to improve the safety and the efficacy of Carmustine wafer implantation. More than eight Carmustine wafers could be implanted in large surgical cavities with survival benefits for the patients.
Medical subject headings
- Antineoplastic Agents, Alkylating
- Brain Neoplasms
- Carmustine
- Glioblastoma
- Neurosurgical Procedures